Cargando…

Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer

BACKGROUND: Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The turnaround time is one of important issues to deliver results timely for clinical decisions. The Ion Torrent™ Genexus™ Integrated Sequencer automates all next generation sequencing (NGS) workflows...

Descripción completa

Detalles Bibliográficos
Autores principales:	Low, Siew-Kee, Ariyasu, Ryo, Uchibori, Ken, Hayashi, Rie, Chan, Hiu Ting, Chin, Yoon Ming, Akita, Takahiro, Harutani, Yuhei, Kiritani, Ayu, Tsugitomi, Ryosuke, Manabe, Ryo, Ogusu, Shinsuke, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Nakamura, Yusuke, Nishio, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186171/ https://www.ncbi.nlm.nih.gov/pubmed/35693289 http://dx.doi.org/10.21037/tlcr-21-981

Ejemplares similares

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
por: Ariyasu, Ryo, et al.
Publicado: (2023)

Clinical characteristics of patients with KRAS mutation detected by liquid biopsy
por: Amino, Yoshiaki, et al.
Publicado: (2023)

Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2
por: Uchibori, Ken, et al.
Publicado: (2021)

Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib
por: Sakamoto, Hiroaki, et al.
Publicado: (2021)

Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice
por: Ariyasu, Ryo, et al.
Publicado: (2020)

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases
por: Tozuka, Takehiro, et al.
Publicado: (2020)

Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancer
por: Ogusu, Shinsuke, et al.
Publicado: (2023)

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients
por: Kitazono, Satoru, et al.
Publicado: (2019)

SDPS-44 RAPID DETECTION OF MUTATIONS IN CSF-CFTNA WITH THE GENEXUS INTEGRATED SEQUENCER
por: Arjuna, Srividya, et al.
Publicado: (2023)

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR
por: Ariyasu, Ryo, et al.
Publicado: (2021)

Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus
por: Vestergaard, Lau K., et al.
Publicado: (2021)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
por: Yoshizawa, Takahiro, et al.
Publicado: (2021)

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors
por: Tozuka, Takehiro, et al.
Publicado: (2020)

Performance of Oncomine Fusion Transcript kit for formalin‐fixed, paraffin‐embedded lung cancer specimens
por: Sakai, Kazuko, et al.
Publicado: (2019)

Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
por: Yanagitani, Noriko, et al.
Publicado: (2020)

Validation of the Oncomine(™) focus panel for next-generation sequencing of clinical tumour samples
por: Williams, Hannah L., et al.
Publicado: (2018)

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021‐01)
por: Uematsu, Shinya, et al.
Publicado: (2022)

Expression patterns and clinical significances of PBK in lung cancer: an analysis based on Oncomine database
por: Li, Jinglei, et al.
Publicado: (2021)

Expression patterns and clinical significances of ENO2 in lung cancer: an analysis based on Oncomine database
por: Liu, Desen, et al.
Publicado: (2020)

Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer
por: Park, Joonhong, et al.
Publicado: (2020)

Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations
por: Cho, Yong Gon, et al.
Publicado: (2023)

RS3PE syndrome developing during the course of probable toxic shock syndrome: a case report
por: Kyotani, Moe, et al.
Publicado: (2018)

Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis
por: Wilson, Brian J, et al.
Publicado: (2007)

A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays
por: Chaudhary, Sanjib, et al.
Publicado: (2017)

Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases
por: Cai, Pan, et al.
Publicado: (2021)

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
por: Sakashita, Takuya, et al.
Publicado: (2022)

Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing
por: Shin, Saeam, et al.
Publicado: (2017)

Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter
por: Hou, Guo-Xin, et al.
Publicado: (2017)

Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study
por: Bamba-Funck, Jessica, et al.
Publicado: (2023)

GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer
por: Shimizu, Yuki, et al.
Publicado: (2022)

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer
por: Takahashi, Ken, et al.
Publicado: (2020)

PTEN, A Target of Microrna-374b, Contributes to the Radiosensitivity of Canine Oral Melanoma Cells
por: Noguchi, Shunsuke, et al.
Publicado: (2019)

Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer
por: Ozawa, Yuichi, et al.
Publicado: (2020)

基于Oncomine数据库荟萃分析KIF23在非小细胞肺癌中的表达和意义
Publicado: (2017)

Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases
por: Liu, Wei, et al.
Publicado: (2018)

Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database
por: Quan, Li-Li, et al.
Publicado: (2021)

Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples
por: Nemoto, Daiji, et al.
Publicado: (2020)

Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2022)

Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation
por: Sakaguchi, Tadashi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tc3ml140mf1bi0fhaghldua9ki